Patent · US Expired

Imidazonaphthyridines

US6194425A · kind A · utility

254Cited by
24References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 11, 1998
Grant dateFeb 27, 2001
Priority date
Expiry dateDec 11, 2018

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.